Shree Ganesh Bio-Tech reduces stake in Suncare Traders to 1.89%

Shree Ganesh Bio-Tech (India) Ltd has reduced its shareholding in Suncare Traders Ltd to 1.89% following the sale of 86,48,166 equity shares. The shares were sold via open market transactions between April 1 and June 22, 2026, according to a disclosure submitted under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Prior to the transaction, Shree Ganesh Bio-Tech held 1,34,58,166 shares, representing a 5.28% stake in the company. The acquirer does not belong to the promoter or promoter group of Suncare Traders. The total equity share capital of Suncare Traders remains Rs. 51,00,00,000, divided into 25,50,00,000 equity shares of Rs. 2 each.

The disclosure confirms that there were no changes to the company's equity structure or total voting capital as a result of the transaction. The diluted share capital also remains unchanged at Rs. 51,00,00,000. No shares were held under encumbrance or through warrants and convertible securities either before or after the sale.

Shareholding Details

The following table outlines the changes in shareholding patterns for Shree Ganesh Bio-Tech (India) Ltd:

Particulars	Number of Shares	% of Total Share Capital	% of Diluted Share Capital
Before Sale
Shares carrying voting rights	1,34,58,166	5.28	5.28
Transaction
Shares sold	86,48,166	3.39	3.39
After Sale
Shares carrying voting rights	48,10,000	1.89	1.89

The shares of Suncare Traders Ltd are listed on BSE Limited with the scrip code 539526.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.00%	+2.13%	+4.35%	-30.43%	-49.47%	-36.84%

Suncare Traders Limited has filed a regulatory disclosure with BSE Limited under Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, dated May 07, 2026. The filing confirms that the company has no funds remaining unutilized as on March 31, 2026, or as on the date of the disclosure, from any capital-raising exercise undertaken in the past.

Regulatory Background

The disclosure was made in compliance with SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019, which mandates listed companies to submit periodic statements on any deviation or variation in the utilization of proceeds raised through public issues, rights issues, preferential issues, or qualified institutional placements (QIPs). Regulation 32(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 forms the overarching framework governing such disclosures.

Key Disclosure Details

The following table summarizes the key parameters of the regulatory filing:

Parameter:	Details
Filing Date:	May 07, 2026
Regulation:	Regulation 32(1), SEBI (LODR) Regulations, 2015
SEBI Circular Reference:	CIR/CFD/CMD1/162/2019 dated December 24, 2019
Reporting Period:	As on March 31, 2026
Unutilized Funds:	Nil
Annexure-A Required:	No
Signatory:	Harshad Rathod, Wholetime Director

Company's Statement

Suncare Traders Limited explicitly stated that the company does not have any funds remaining unutilized as on March 31, 2026, or as on date, out of the proceeds of public issue, rights issue, preferential issue, qualified institutional placement (QIP), etc., if any undertaken by it at any time in the past. In view of this position, the company has confirmed that no information is required to be provided by way of Annexure-A pursuant to the said regulation or circular.

The disclosure was digitally signed by Harshad Rathod, Wholetime Director, on May 07, 2026, and submitted to the Listing Department of BSE Limited, P J Tower, Dalal Street, Mumbai – 400001.